Staged Diabetes Management: A Systematic Approach

Using evidence–based medicine, this title addresses the prominent issues of primary care diabetes management. It provides practical solutions to the detection and treatment of diabetes, its complications and such new areas as metabolic syndrome, pre–diabetes and diabetes in children. The text reviews the fundamental basis of diabetes management and then addresses treatment of each type of diabetes and the major micro– and macrovascular complications.
This Revised Second Edition uniquely focuses on advanced technologies and advanced therapeutics. Key changes include: Integration of incretin hormones in the basic pathophysiology of type 2 diabetes; Incretin mimetics and potentiators; Revised clinical decision paths with new medications and advanced insulin algorithms; New section on continuous glucose monitoring.
Staged Diabetes Management: A Systematic Approach, Second Edition, Revised presents a clear set of clinical algorithms consistent with the EASD/ADA recommended algorithms. It provides a means of applying the principles using a proven methodology and one that has been applied internationally.Based on the highly successful diabetes programmes for primary care developed by the world–renowned International Diabetes Center in Minneapolis, USAFeatures Decision Paths and Practice Guidelines to facilitate clinical decision makingClearly written and illustrated: each chapter may be read alone but complements the others to give a broad view of diabetes careThis title is an invaluable guide for healthcare professionals, particularly primary care physicians, diabetes specialist nurses, and for all those with an interest in diabetes. It is also useful for all Diabetes educators and medical students.

Spis treści:
About the Authors.
Acknowledgements.
PART ONE STAGED DIABETES MANAGEMENT IN PRACTICE.
1 Introduction to Staged Diabete s Management.
The development of Staged Diabetes Management.
The structure of Staged Diabetes Management.
Practice guidelines.
Master DecisionPaths.
Specific DecisionPaths.
Criteria for adjusting and changing therapy.
Diabetes Management Assessment DecisionPaths.
Metabolic syndrome, complications, and hospitalization DecisionPaths.
The patient and Staged Diabetes Management.
The diabetes care team.
The changing perspective of diabetes care: DCCT and UKPDS.
Metabolic syndrome (insulin resistance syndrome).
Children and adolescents with type 2 diabetes and/or metabolic syndrome.
Common diagnostic criteria.
Diabetes management improvement initiatives.
References.
2 The Implementation of Staged Diabetes Management.
Community diabetes care needs assessment.
Group formation.
Orientation to Staged Diabetes Management.
Customization of Staged Diabetes Management.
Evaluation of Staged Diabetes Management.
References.
3 Therapeutic Principles for the Treatment of Diabetes.
Medical nutrition therapy stage.
Oral agent stage.
Insulin stage.
Combination therapies.
Evaluating blood glucose control.
References.
PART TWO THE TREATMENT OF DIABETES.
4 Type 2 Diabetes.
Etiology.
Overview of treatment options for type 2 diabetes.
Prevention of type 2 diabetes.
Type 2 diabetes detection and treatment.
Type 2 Diabetes Practice Guidelines.
Type 2 Diabetes Master DecisionPath.
New treatment alternatives.
Management of acute complications.
Type 2 diabetes and pregnancy.
Patient education.
Behavioral issues and assessment.
References.
5 Type 2 Diabetes and Metabolic Syndrome in Children and Adolescents.
Etiology.
Prevention of type 2 diabetes.
Major studies.
Overview of treatment options for children and adolescents with type 2 diabetes.
Obesity and weight management in children and adolescents.
Type 2 diabetes in children and adolescents.
Metabolic syndrome in children and adolescents.
References.
6 Type 1 Diabetes.
Etiology.
Type 1 diabetes detection and treatment.
Type 1 Diabetes Practice Guidelines.
Screening and Diagnosis DecisionPath.
Type 1 Diabetes Master DecisionPath.
Management of acute complications.
Type 1 diabetes and pregnancy.
Patient education.
Behavioral issues and assessment.
References.
7 Pregestational and Gestational Diabetes.
Etiology of GDM and hyperglycemia.
Adverse fetal and perinatal outcome.
Preventing gestational diabetes and subsequent type 2 diabetes.
Pregestational diabetes.
Gestational diabetes detection and treatment.
Gestational diabetes practice guidelines.
Gestational Diabetes Master DecisionPath.
Pregestational (type 1 and type 2) diabetes treatment options.
Fetal and maternal assessment.
References.
PART THREE INSULIN RESISTANCE AND DIABETES COMPLICATIONS.
Overview.
Metabolic syndrome (insulin resistance syndrome) and complications.
Hospitalization overview.
8 Macrovascular Disease.
Diabetes and the risk of cardiovascular disease.
Role of inflammation in macrovascular disease.
Prevention of cardiovascular disease in diabetes: importance of a multifactorial approach.
Insulin resistance, hypertension, and cardiovascular disease.
Detection and treatment of hyperglycemia, hypertension, and dyslipidemia.
Practice guidelines: hypertension and dyslipidemia.
Staged management of hypertension.
Staged management of hyperlipidemia and dyslipidemia.
Additional therapeutic options for prevention and treatment of cardiovascular disease.
References.
9 Microvascular Complications.
Detection and treatment of diabetic nephropathy.
Detection and treatment of eye complications.
Detection and treatment of diabetic neuropathy.
Detection and treatment of foot complications.
Detecti on and treatment of dermatological, connective tissue, and oral complications.
Polycystic ovary syndrome (PCOS).
References.
10 Hospitalization.
The current impact of diabetes related hospitalizations.
Hospitalization practice guidelines.
Hospitalization for problems related to glycemic control.
Hospitalization for illness.
Hospitalization for surgery.
Reference.
Appendix.
Index.

Nota biograficzna:
Roger S. Mazze, PhD, Chief Academic Officer, International Diabetes Center, Vice President, Park Nicollet Institute. Director, World Health Organization Collaborating Center at International Diabetes Center and Clinical Professor of Family Practice and Community Health, University of Minnesota Medical School. Formerly, Professor of Biostatistics, Epidemiology and Community Health, and Executive Director and Co–Principal Investigator of the Diabetes Research and Training Center, Albert Einstein College of Medicine and Distinguished Visiting Scientist to the United States Centers for Disease Control. Past Co–Chairperson, American Diabetes Association Council on Health Care Delivery.
Ellie S. Strock, RN, BC, ANP, CDE, Chief of Professional Services, International Diabetes Center, Vice President, Park Nicollet Institute. Chief Education Director, World Health Organization Collaborating Center at International Diabetes Center. Board Certified Adult Nurse Practitioner, Department of Endocrinology, Park Nicollet Health Services.
Gregg D. Simonson, PhD, Director, Program Research and Implementation and Chief Research Officer, World Health Organization Collaborating Center at International Diabetes Center. Adjunct Assistant Professor, Department of Family Practice and Community Health, University of Minnesota Medical School. Formerly, Post–Doctoral Fellow, Juvenile Diabetes Foundation, Department of Pediatrics, University of Wisconsin.
Richard M. Bergenstal, M